KALYTERA THERAPEUTICS Forum: Community User: Newbie1

https://www.globenewswire.com/news-release/2019/08/19/1903469/0/en/Kalytera-to-Conclude-Phase-2-Clinical-Study-and-Initiate-Phase-3-Study.html

Sehr schöne News! Trial 2 beendet. Und auf nach Trial 3

Das wäre übel. Denn dann würde die runter geshortet worden ohne Ende Also erstmal eine gute Nachricht

Also aus z.B. 12 je 2 Cent Aktien wird eine zu 24 Cent

Das heißt dass es keinen Reverse Split gibt.

Was bedeutet das?

Eben hier auch gelesen. Richtig gut!

http://thedeepdive.ca/kalytera-therapeutics-cancels-potential-reverse-split-transaction/

https://www.sedar.com/GetFile.do?lang=EN&docClass=8&issuerNo=00021766&issuerType=03&projectNo=02943993&docId=4562061

Nice

RS ist History

"If the stock price was to hit $0.10, the B warrants I purchased would be intrinsically worth $0.035 with some added time value. At $0.15, the warrants would be intrinsically worth $0.085 with some possible time value. At a purchase price of $0.015, that is more than double to nearly five times one's money, excluding any possible time value. The warrants offer cheap leveraged upside and given their time to expiry compared to my timeline for this investment, are a no-brainer to me compared to simply owning the stock. I encourage investors to analyze the merits and risks of holding either the stock or the warrants themselves."

"My bullish thesis on Kalytera is relatively straightforward: The Phase 2 study will continue to show success with minimal or none of the patients enrolled developing GVHD in the months following a transplant. Kalytera will be able to attract a partner that can finance a Phase 3 study and New Drug Application, thus limiting or eliminating any further dilution. These items will occur in the early to mid-fall when the typical summer slumber ends for Canadian penny stocks and bullish excitement returns to the cannabis and CBD sectors."

Richtig guter Artikel! https://seekingalpha.com/article/4276519-kalytera-therapeutics-banking-partnership-diluted-cbd-medical-play-upcoming-catalysts

Selbst beantwortet 😉 "Meeting is Monday July 29th, not this Monday but the following. Investors not able to make the meeting have until midnight July 24th to vote."